Comparison of Superficial-Only Versus Combined Indocyanine Green Injection Techniques for Sentinel Lymph Node Mapping in Patients With Endometrial Cancer

Brief summary (registry, in English)

This Clinical trial will compare ICG cervical superficial injections versus superficial and deep injection for sentinel lymph node mapping in early-stage endometrial cancer patients

What you commit to

• Study type: Interventional
• Planned participants: 200
• From 1 Dec 2026 to the primary completion date, Aug 2030
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with stage I endometrial cancer who have sentinel lymph node mapping with ICG dye, using keyhole (laparoscopic or robotic) surgery.

Age

18 years or older

Sex

Women only

Disease stage

Confirmed stage I endometrial cancer

Earlier treatment

Must not have had pelvic radiotherapy. Must not have had a previous gynecologic cancer disease.

Main reasons for not taking part

• Allergic reaction to ICG or iodine
• Previous gynecologic oncology disease
• Previous pelvic radiotherapy

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov